Cigna says it will end drug rebates as pressure mounts on PBMs
信诺(Cigna)称将逐步停止接受药品回扣，PBM 面临的压力与日俱增

Cigna said it will move away from receiving drug rebates, an opaque part of the US drug pricing formula that has drawn increased scrutiny from federal and state lawmakers.
信诺集团(Cigna)表示，将逐步摆脱按惯例收取药品回扣的做法——这一美国药价机制中不透明的环节，近年来日益受到联邦与各州立法者的审查。